A Phase 1 Study To Evaluate Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Antistaphylococcal Lysin LSVT-1701 in Healthy Adult Subjects.

Wire, Mary Beth; Jun, Soo Youn; Jang, In-Jin; Lee, Seung-Hwan; Hwang, Jun Gi; Huang, David B

Wire, Mary Beth; Jun, Soo Youn; Jang, In-Jin; Lee, Seung-Hwan; Hwang, Jun Gi; Huang, David B.

Afiliación

Wire MB; Lysovant Sciences, Inc., New York, New York, USA.
Jun SY; iNtRON Biotechnology, Inc., Seongnam-si, Gyeonggi-do, Republic of Korea.
Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Lee SH; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Hwang JG; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Huang DB; Lysovant Sciences, Inc., New York, New York, USA.

Antimicrob Agents Chemother ; 66(3): e0184221, 2022 03 15.

Article en En | MEDLINE | ID: mdl-35007129

Asunto(s)

Cefalea; Adulto; Relación Dosis-Respuesta a Droga; Método Doble Ciego; Voluntarios Sanos; Humanos; Masculino

Palabras clave

LSVT-1701; SAL200; bacteriophage; lysin; pharmacokinetics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cefalea Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google